Brief: FDA Approves Fam-Trastuzumab Deruxtecan-Nxki With Pertuzumab

Daiichi Sankyo

15/12/2025 19:07

Dec 15 (Reuters) - FDA:

FDA APPROVES FAM-TRASTUZUMAB DERUXTECAN-NXKI WITH PERTUZUMAB FOR UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER- WEBSITE